1. Home
  2. CRAI vs ALVO Comparison

CRAI vs ALVO Comparison

Compare CRAI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

HOLD

Current Price

$165.22

Market Cap

1.2B

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$6.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRAI
ALVO
Founded
1965
2013
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
CRAI
ALVO
Price
$165.22
$6.15
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
★ $245.00
$8.00
AVG Volume (30 Days)
89.6K
★ 981.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
★ 1.48%
N/A
EPS Growth
★ 20.77
N/A
EPS
★ 8.14
N/A
Revenue
★ $751,583,000.00
N/A
Revenue This Year
$7.82
$13.28
Revenue Next Year
$5.14
$18.63
P/E Ratio
$19.91
★ $18.20
Revenue Growth
★ 9.33
N/A
52 Week Low
$132.17
$2.94
52 Week High
$227.29
$9.05

Technical Indicators

Market Signals
Indicator
CRAI
ALVO
Relative Strength Index (RSI) 44.75 73.77
Support Level $152.37 $3.10
Resistance Level $166.99 N/A
Average True Range (ATR) 5.22 0.27
MACD -0.30 0.02
Stochastic Oscillator 46.90 95.83

Price Performance

Historical Comparison
CRAI
ALVO

About CRAI CRA International Inc.

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: